Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 177, pseudogene (RNU6-177P) is a genomic sequence classified as a pseudogene related to U6 small nuclear RNA, found at chromosome 7q32[3][1]. Unlike the canonical U6 small nuclear RNA, an essential component of the spliceosome involved in mRNA splicing, RNU6-177P does not encode a functional RNA or protein and has no confirmed biological activity, therapeutic relevance, or known disease association[1][3]. Pseudogenes such as RNU6-177P are typically nonfunctional vestiges of related functional genes and do not serve as direct drug or biomarker targets. The target (RNU6-177P) is not a functional gene or valid therapeutic target but a pseudogene, so relevant data for normal targets—such as drugs, mechanisms, or disease links—do not apply[1][3]. The entry is not incorrect as a name for the pseudogene but incorrect as a valid biological/therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 177, pseudogene (RNU6-177P).